Wordt geladen...
An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases
Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. Omalizumab is the unique biologic treatment registered for asthma therapy in children. The clinical efficacy and safety of omalizumab treatment in the pediatric population has been extensively...
Bewaard in:
| Gepubliceerd in: | Curr Respir Med Rev |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Bentham Science Publishers
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735517/ https://ncbi.nlm.nih.gov/pubmed/29290750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1573398X13666170616110738 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|